Stapokibart shows promise in reducing nasal congestion in seasonal allergy patients, study finds Post author: Post published:February 9, 2024 Post category:uncategorized The efficacy and safety of stapokibart as an in patients with seasonal allergic rhinitis (SAR). You Might Also Like Gender differences explored: Cardiovascular health variances in women’s lifespan February 27, 2024 Scientists create single-cell atlas of spinal neurons involved in motor coordination August 10, 2026 Evosep launches IQ/OQ protocols for the Evosep Eno System at WCBP 2026 January 30, 2026